This study will collect MRI from healthy volunteer boys and boys with Duchenne Muscular Dystrophy (DMD) to help researchers identify and validate cardiac MRI biomarkers to better understand the health of the heart and changes in heart health over time in boys with DMD. Currently, there is a lack of sufficiently well characterized cardiac MRI biomarkers that can serve as endpoints for detecting on-target and/or off-target cardiac effects during clinical drug trials for boys with DMD. Consequently, the first objective is to identify and characterize several cardiac MRI biomarkers for boys with DMD.
The second objective is to use their well-characterized cardiac MRI biomarkers and define their sensitivity for detecting early cardiac involvement. The final objective is to use these validated cardiac MRI biomarkers to better understand the genotype-phenotype correlation in boys with DMD, which to date remain tenuous. The investigators propose a pilot study to explore cardiac genotype-phenotype correlations in boys with DMD and outlier phenotypes using approaches they have pioneered for skeletal muscle.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
89
University of California, Los Angeles
Los Angeles, California, United States
Children's Hospital of Orange County
Orange, California, United States
Stanford University
Stanford, California, United States
Myocardial Tissue Characterization
Focal and diffuse fibrosis, intra myocardial fat, edema plus water mobility
Time frame: 6 months
Myocardial Functional Characterization
Strain imaging and rotational mechanics
Time frame: 6 months
Genomic Analysis
Proposing mechanisms of cardiac dysfunction or protective phenotypes using genomic analysis
Time frame: 4 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Holter Monitor
Pulmonary Function Test
Genetic Testing
Repeat MRI scan